NCT05664074View on ClinicalTrials.gov

Rectal Indomethacin vs Intravenous Ketorolac

PHASE4RecruitingINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

November 7, 2022

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions
Post-ERCP Acute Pancreatitis
Interventions
DRUG

Rectal indomethacin

"Dosage based on subject's weight:~\>=50 kg, 100 mg; 30-49 kg, 50 mg; 10-29 kg, 25 mg"

DRUG

IV ketorolac

Dosage based on subject's weight: 0.5 mg/kg (maximum: 15 mg)

Trial Locations (1)

45229

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

David Vitale MD

OTHER